Business Context and Reporting Period
This Form 8-K Current Report was filed by Aspen Aerogels, Inc. on June 15, 2023. The filing addresses the termination of a material definitive agreement regarding the company's equity offering program.
Key Financial Metrics
The filing does not provide standard financial statements such as revenue, profit, cash flow, or margins. However, it discloses specific capital raising metrics related to the terminated agreement:
- Program Capacity: Up to $150,000,000 in aggregate offering sales proceeds.
- Shares Sold: 5,241,400 shares of common stock.
- Net Proceeds Received: $72.7 million since the program's inception on March 16, 2022.
- Termination Penalties: None.
Material Changes
The primary material change is the termination of the Sales Agreement dated March 16, 2022, with Cowen and Company, LLC and Piper Sandler & Co. (the "2022 ATM Offering Program").
- Notice Date: June 15, 2023.
- Effective Termination Date: June 20, 2023.
- Future Sales: The Company will not make any further sales under this agreement.
Outlook and Management Commentary
Management announced the termination via a press release dated June 15, 2023. The filing confirms that the Company is not subject to any termination penalties. No specific forward-looking guidance, risk factors, or contingencies beyond the termination of the sales agreement are detailed in this specific report.
Investor Verification Checklist
- Verify the exact number of shares sold (5,241,400) and net proceeds ($72.7 million) against the company's most recent 10-Q or 10-K filings.
- Confirm the effective date of termination (June 20, 2023) to ensure no sales occurred after this date.
- Review the attached press release (Exhibit 99.1) for additional context on the strategic rationale for ending the ATM program.
- Check for any new equity financing arrangements announced concurrently with this termination.